Document:

EX-4.10

 Exhibit 4.10 

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AS AMENDED (the “1933
ACT”), OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO YOU THAT SUCH
REGISTRATION IS NOT REQUIRED UNDER THE 1933 ACT, OR ANY APPLICABLE STATE SECURITIES LAWS. 
 AMENDED AND RESTATED PLAIN ENGLISH WARRANT
AGREEMENT 
 This is a AMENDED AND RESTATED PLAIN ENGLISH WARRANT AGREEMENT dated December 15, 2011 by and between BLOOM ENERGY CORPORATION, a
Delaware corporation, and TRIPLEPOINT CAPITAL LLC, a Delaware limited liability company. 
 The words “We”, “Us”, or “Our”
refer to the warrant holder, which is TRIPLEPOINT CAPITAL LLC. The words “You” or “Your” refers to the issuer, which is BLOOM ENERGY CORPORATION, and not to any individual. The words “the Parties” refers to both
TRIPLEPOINT CAPITAL LLC and BLOOM ENERGY CORPORATION. This Amended and Restated Plain English Warrant Agreement may be referred to as the “Warrant Agreement”. 

RECITALS 
 WHEREAS,
the Parties have entered into a Plain English Warrant Agreement (0674-W-01) dated as of December 31, 2010 (the “Original Warrant”); 

WHEREAS, the Parties have entered into a Plain English Master Lease Agreement dated as of December 31, 2010, and related Software or
Hardware Facility Schedules and Summary Schedules which are collectively referred to in this Warrant Agreement as the “Lease Agreement”. 

WHEREAS, the Parties have agreed to transfer the commitment amounts under the Lease Agreement to an equipment loan agreement (the
“Transfer”) as set forth in that certain Plain English Equipment Loan and Security Agreement dated as of December 15, 2011 by and between the Parties (the “Loan Agreement”) 

WHEREAS, in accordance with Section 11 of the Original Warrant, any provision of the Original Warrant may be amended by a written
instrument signed by the Parties; and 
 WHEREAS, the Parties hereby desire to amend and restated the Original Warrant to give effect to the
Transfer and wish to do so on the terms and conditions set forth herin. 
 In consideration of the Parties continuing performance and obligations under the
Loan Agreement and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree to the following mutual agreements and conditions set forth below: 

 

					
	 WARRANT INFORMATION

 

			
	 Effective Date

December 31,2010
	  	 Warrant Number

0674-W-01
	  	 Lease Facility Schedules

0674-LE-01H/-01S

  

					
		  	1	  	

							
	 Warrant
Coverage
	  	 Number of Shares
	  	 Price Per Share
	  	 Type of Stock

	$300,000 (3% of $10,000,000); additional warrant coverage as set forth in Section 1.	  	 16,198; plus additional shares as set forth in Section 1. The Number of

Shares is subject to adjustment as set forth in this Warrant Agreement.
	  	$18.52 subject to
adjustment as set forth in
this Warrant Agreement	  	Series F Preferred Stock;
subject to the provisions of
Section 1.

  

					
	OUR CONTACT INFORMATION
			
	 Name

TriplePoint Capital LLC
	  	 Address For Notices

2755 Sand Hill Road, Ste. 150
 Menlo
Park, CA 94025
 Tel: (650) 854-2090

Fax: (650) 854-1850
	  	Contact Person
 Sajal Srivastava, COO

Tel: (650) 233-2102
 Fax: (650)
854-1850
email: legal@triplepointcapital.com

	  
 YOUR
CONTACT INFORMATION

			
	 Customer Name

Bloom Energy Corporation
	  	 Address For Notices

1252 Orleans Drive
 Sunnyvale, CA
94089
	  	Contact Person
 William Kurtz, CFO

Tel: (408) 543-1550
 Fax: (408)
543-1501
 email: wkurtz@bloomenergy.com

  

	1.	WHAT YOU AGREE TO GRANT US 

 You grant to Us and We are entitled, upon the terms and subject to the
conditions set forth in this Warrant Agreement, to purchase from You, at a price per share equal to the Exercise Price, that number of fully paid and non-assessable shares of Your Warrant Stock equal to Three Hundred Thousand Dollars ($300,000),
divided by the Exercise Price (rounded down to the nearest whole share). 
 In addition, You grant to Us and We are entitled, upon the terms and subject to
the conditions set forth in this Warrant Agreement, to purchase from You, at a price per share equal to the Exercise Price, an additional number of fully paid and non-assessable shares of Your Warrant Stock (rounded down to the nearest whole share)
equal to: 
  

	 	Þ	one-half percent (0.5%) of any amounts advanced under Part 1 of the Loan Agreement, divided by the Exercise Price, if You choose Option B for such Advance under the Loan Agreement; or 

 

	 	Þ	one percent (1.0%) of any amounts advanced under Part 1 of the Loan Agreement, divided by the Exercise Price, if You choose Option C for such Advance under the Loan Agreement. 

The number of shares of Warrant Stock and the Exercise Price of such Warrant Stock are subject to adjustment as provided in Section 4 hereof. 

For purposes of this Warrant Agreement, the following capitalized terms have the meanings given below: 

“Exercise Price” means the lower of (a) $18.52 and (b) the lowest per share price for which Your preferred stock is sold in
the Next Round. 
 “Next Round” means the next bona fide round of equity financing in which You issue and sell shares of your
preferred stock for aggregate gross cash proceeds of at least $1,000,000 (excluding any amounts received upon conversion or cancellation of indebtedness) subsequent to the Effective Date. 

“Warrant Stock” means (a) the class and series of Your preferred stock issued in the Next Round, if the lowest per share price
for which such preferred stock is sold in the Next Round is less than $18.52, or (b) in all other cases, Your Series F Preferred Stock. For avoidance of doubt, if this Warrant Agreement is exercised prior to the Next Round then this Warrant
Agreement shall be exercisable for Your Series F Preferred Stock. 
 The Parties agree that this Warrant Agreement to purchase the Warrant Stock has a fair
market value equal to $100 and that $100 of the issue price of the investment will be allocable to the Warrant Agreement and the balance shall be allocable to the Loan Agreement for income tax purposes and the original issue discount on the Loan
Agreement shall be considered to be zero. 

  

					
		  	2	  	

	2.	WHEN ARE WE ENTITLED TO PURCHASE YOUR WARRANT STOCK. 

 The term of this Warrant Agreement and our right
to purchase Warrant Stock will begin on the Effective Date, and shall be available for a period often (10) years up to and including December 31, 2020. 

Notwithstanding the foregoing, Our right to purchase the Warrant Stock shall be automatically and fully exercised via the net issuance method described below
(without surrender of the Warrant Agreement) upon the occurrence of a Merger Event, as defined below, with a Person that is not one of Your affiliates, in which Your common stock is exchanged for cash and/or stock that is traded on a recognized
public exchange or on the NASDAQ National Market, provided that, upon consummation of the Merger Event, the consideration payable to Us pursuant to such exercise and on account of the Warrant Stock consists of (i) cash or (ii) stock that
is traded on a recognized public exchange or on the NASDAQ National Market. No less than ten (10) business days prior to any Merger Event, You shall provide Us with written notice of the proposed Merger Event together with a copy of the
executed merger agreement, or other definitive documentation (and all schedules and exhibits thereto) and information concerning Your expected capitalization immediately prior to the Merger Event. Upon consummation of the Merger Event, You shall
promptly provide Us with (a) a copy of any modifications or amendments to the executed merger agreement, (b) any other documents in connection therewith, (c) updated information, if any, concerning Your capitalization immediately
prior to the Merger Event, and, (d) upon request, by Us any other information reasonably necessary to an informed evaluation of Our rights under this Agreement. 
  

	3.	HOW WE MAY PURCHASE YOUR WARRANT STOCK. 

 We may exercise Our purchase rights, in whole or in part, at
any time, or from time to time, prior to the expiration of the term of this Warrant Agreement, by giving You a completed and executed Notice of Exercise in the form attached as Exhibit I. Promptly upon receipt of the Notice of Exercise
and in any event no later than twenty-one (21) days after you have received Our Notice of Exercise and payment of the aggregate Exercise Price for the shares purchased, You will issue to Us a certificate for the number of shares of Warrant
Stock that We have purchased and You will execute the Acknowledgment of Exercise in the form attached hereto as Exhibit II indicating the number of shares which will be available to Us for future purchases, if any. 

We may pay for the Warrant Stock by either (i) cash or check, or (ii) by the net issuance method as determined below. If We elect the Net
Issuance method, You will issue Warrant Stock using the following formula: 
 X = Y(A-B)  

A 
  

					
	 Where:
	  	X =	  	the number of shares of Warrant Stock to be issued to Us.
			
		  	Y =	  	the number of shares of Warrant Stock We request to be exercised under this Warrant Agreement.
			
		  	A =	  	the fair market value of one share of Warrant Stock.
			
		  	B =	  	the Exercise Price.

 For purposes of the above calculation, current fair market value of Warrant Stock shall mean with respect to each share of
Warrant Stock: 
 If the exercise is in connection with the initial public offering of Your Common Stock, and if Your registration statement relating
to such public offering has been declared effective by the SEC, then the fair market value per share shall be the product of (x) the initial “Price to Public” specified in the final prospectus of the offering and (y) the number
of shares of Common Stock into which each share of Warrant Stock is convertible at the time of such exercise; 
 If this Warrant Agreement is exercised
after, and not in connection with Your initial public offering, and: 
  

	Þ	if traded on a securities exchange, the fair market value shall be the product of (x) the average of the closing prices over a five (5) day period ending three (3) days before the day the current fair
market value of the securities is being determined and (y) the number of shares of Common Stock into which each share of Warrant Stock is convertible at the time of such exercise; or 

  

					
		  	3	  	

	Þ	if actively traded over-the-counter, the fair market value shall be the product of (x) the average of the closing bid and asked prices quoted on the NASDAQ system (or similar system) over the five (5) day
period ending three (3) days before the day the current fair market value of the securities is being determined and (y) the number of shares of Common Stock into which each share of Warrant Stock is convertible at the time of such
exercise. 

 If this Warrant Agreement is exercised prior to or after Your initial public offering, and: 

 

	Þ	Your Common Stock is not listed on any securities exchange or the over-the-counter market, the current fair market value of Warrant Stock shall be the product of (x) the fair market value of a share of Your Common
Stock (the highest price per share which You could obtain from a willing buyer (not a current employee or director) for shares of Common Stock sold, from authorized but unissued shares), as determined in good faith by Your Board of Directors and
(y) the number of shares of Common Stock into which each share of Warrant Stock is convertible at the time of such exercise, unless You shall become subject to a merger, acquisition or other consolidation pursuant to which You are not the
surviving party, in which case the fair market value of Warrant Stock shall be deemed to be the value received by the holders of Your Warrant Stock on a common equivalent basis pursuant to such merger or acquisition or other consolidation.

 During the term of this Warrant Agreement, You will at all times from and after the Effective Date have authorized and reserved a
sufficient number of shares of (a) Warrant Stock to provide for the exercise of our rights to purchase Warrant Stock, and (b) Common Stock to provide for the conversion of the Warrant Stock. 

If We elect to exercise part of the Warrant Agreement, You will promptly issue to Us an amended Warrant Agreement stating the remaining number of shares that
are available. All other terms and conditions of that amended Warrant Agreement shall be identical to those contained in this Warrant Agreement. 
 If at
the end of the term of this Warrant Agreement, the fair market value of one share of Warrant Stock (or other security issuable upon the exercise hereof) as determined in accordance herewith is greater than the Exercise Price in effect on such date,
then this Warrant Agreement shall automatically be deemed on and as of such date to be converted pursuant hereto as to all shares of Warrant Stock (or such other securities) for which it shall not previously have been exercised or converted, and You
shall promptly deliver a certificate representing the shares of Warrant Stock (or such other securities) issued upon such conversion to Us. 
  

	4.	WHEN WILL THE NUMBER OF SHARES AND EXERCISE PRICE CHANGE. 

  

	Þ	If You are Acquired. If at any time: (i) there is a reorganization of Your stock (other than a reclassification, exchange or subdivision of Your stock otherwise provided for in this Warrant Agreement);
(ii) You merge or consolidate with or into another entity, whether or not You are the surviving entity; or (iii) there occurs any transaction or series of related transactions that result in the transfer of fifty percent (50%) or more
of the outstanding voting power of the capital stock of You (each of the foregoing events are referred to as a “Merger Event”), then, as a part of such Merger Event, lawful provision shall be made so that We shall thereafter be entitled to
receive, upon exercise of Our rights under this Warrant Agreement, the number of shares of preferred stock or other securities of the successor or surviving person resulting from such Merger Event, equal in value to that which would have been
issuable if We had exercised Our rights under this Warrant Agreement immediately prior to the Merger Event. In any such case, appropriate adjustment (as determined in good faith by Your Board of Directors) shall be made in the application of the
provisions of this Warrant Agreement with respect to Our rights and interest after the Merger Event so that the provisions of this Warrant Agreement (including adjustments of the Exercise Price and number of shares of Warrant Stock purchasable)
shall be applicable to the greatest extent possible. 

  

	Þ	If You Reclassify Your Stock. If at any time You combine, reclassify (including by conversion of outstanding preferred stock), exchange or subdivide Your securities or otherwise, change any of the securities as
to which purchase rights under this Warrant Agreement exist into the same or a different number of securities of any other class or classes, this Warrant Agreement will thereafter represent the right to acquire such number and kind of securities as
would have been issuable as the result of such change with respect to the securities which were subject to the purchase rights under this Warrant Agreement immediately prior to such combination, reclassification, exchange, subdivision or other
change. 

  

					
		  	4	  	

	Þ	If You Subdivide or Combine Your Shares. If at any time You combine or subdivide the Warrant Stock, the Exercise Price will be proportionately decreased in the case of a subdivision, or proportionately increased
in the case of a combination. 

  

	Þ	If You Pay Stock Dividends. If at any time You pay a dividend payable in, or make any other distribution (except any distribution specifically provided for in the above paragraphs) of the Warrant Stock, then the
Exercise Price shall be adjusted, from and after the record date of such dividend or distribution, to that price determined by multiplying the Exercise Price in effect immediately prior to such record date by a fraction (i) the numerator of
which shall be the total number of all shares of the Warrant Stock outstanding immediately prior to such dividend or distribution, and (ii) the denominator of which shall be the total number of all shares of the Warrant Stock outstanding
immediately after such dividend or distribution. We will thereafter be entitled to purchase, at the Exercise Price resulting from such adjustment, the number of shares of Warrant Stock (rounded down to the nearest whole share) obtained by
multiplying the Exercise Price in effect immediately prior to such adjustment by the number of shares of Warrant Stock issuable upon the exercise hereof immediately prior to such adjustment and dividing the product thereof by the Exercise Price
resulting from such adjustment. 

  

	Þ	If You Change the Antidilution Rights of the Warrant Stock or Issue New Preferred or Convertible Stock. All antidilution rights applicable to the Warrant Stock purchasable under this Warrant Agreement are as set
forth in Your Certificate of Incorporation, as amended through the Effective Date. You will promptly provide Us with any restatement, amendment, modification of or waiver of any right related to the Warrant Stock under Your Certificate of
Incorporation. You will provide Us with written notice of any issuance of Your stock or other equity security to occur after the Effective Date (other than issuances of stock or equity securities pursuant to customary employee stock plans) that
triggers the antidilution rights applicable to the Warrant Stock, which notice shall include (a) the price at which such stock or security was sold, (b) the number of shares issued, and (c) such other information as necessary for Us
to determine that a dilutive event has occurred as a result of such issuance. 

  

	5.	WE CAN TRANSFER THIS PLAIN ENGLISH WARRANT AGREEMENT. 

 Subject to the terms and conditions contained in
Section 7, We (or any successor transferee) may transfer in whole or in part this Warrant Agreement and all its rights. We agree not to transfer this Warrant Agreement to a competitor of You as determined in good faith by Your board of
directors. You will record the transfer on Your books when You receive Our Notice of Transfer in the form attached hereto as Exhibit III, and Our payment of all transfer taxes and other governmental charges involved in such transfer. 

 

	6.	REPRESENTATIONS, WARRANTIES, AND COVENANTS FROM YOU. 

  

	Þ	Reservation of Warrant Stock. The Warrant Stock issuable upon exercise of Our rights under this Warrant Agreement will be duly and validly reserved and when issued in accordance with the provisions of this
Warrant Agreement will be validly issued, fully paid and non-assessable, and will be free of any taxes, liens, charges or encumbrances of any nature whatsoever; provided, however, that the Warrant Stock issuable pursuant to this Warrant Agreement
may be subject to restrictions on transfer under state and/or Federal securities laws or the Registration Rights Agreement. Upon Our exercise, You will issue to Us certificates for shares of Warrant Stock without charging Us any tax (except as may
be required by applicable law), or other cost incurred by You in connection with such exercise and the related issuance of shares of Warrant Stock. You will not be required to pay any tax, which may be payable in respect of any transfer involved and
the issuance and delivery of any certificate in a name other than TriplePoint Capital LLC. 

  

	Þ	Due Authority. Your execution and delivery of this Warrant Agreement and the performance of Your obligations hereunder, including the issuance to Us of the right to acquire the shares of Warrant Stock, have been
duly authorized by all necessary corporate action on Your part and this Warrant Agreement is not inconsistent with Your Certificate of Incorporation or Bylaws, does not contravene any law or governmental rule, regulation or order applicable to it,
do not and will not contravene any provision of, or constitute a default under, any indenture, mortgage, contract or other instrument to which You are a party or by which You are bound, and this Warrant Agreement constitutes a legal, valid and
binding agreement, enforceable in accordance with its respective terms, subject to laws of general application relating to bankruptcy, insolvency and the relief of debtors and the rules of law or principles at equity governing specific performance,
injunctive relief and other equitable remedies. 

  

					
		  	5	  	

	Þ	Consents and Approvals. No consent or approval of, giving of notice to, registration with, or taking of any other action in respect of any state, Federal or other governmental authority or agency is required with
respect to execution, delivery and Your performance of Your obligations under this Warrant Agreement, except for the filing of any required notices pursuant to Federal and state securities laws, which filings will be effective by the times required
thereby. 

  

	Þ	Issued Securities. All of Your issued and outstanding shares of Common Stock, Warrant Stock or any other securities have been duly authorized and validly issued and are fully paid and nonassessable. All
outstanding shares of Common Stock and Warrant Stock were issued in full compliance with all Federal and state securities laws. In addition as of the Effective Date: 

Your authorized capital consists of (i) 105,608,000 shares of Common Stock, of which 12,027,455 shares of Common Stock are issued and outstanding,
(ii) 14,100,000 shares of Series A Preferred Stock, of which 13,650,000 shares are issued and outstanding, (iii) 12,150,000 shares of Series B Preferred Stock, of which 11,803,284 shares are issued and outstanding, (iv) 9,000,000
shares of Series C Preferred Stock, of which 8,968,604 shares are issued and outstanding, (v) 10,700,000 shares of Series D Preferred Stock, of which 9,481,998 shares are issued and outstanding, (vi) 16,500,000 shares of Series E Preferred
Stock, of which 11,342,180 shares are issued and outstanding, and (vii) 19,908,000 shares of Series F Preferred Stock, of which 18,061,055 shares are issued and outstanding. 

You have reserved 14,493,334 shares of Common Stock for issuance under Your Stock Incentive Plan, under which 7,264,503 options have been granted and are
currently outstanding. You have warrants outstanding to purchase up to 424,342 shares of Series A Preferred Stock, 183,748 shares of Series D Preferred Stock, 4,468,854 shares of Series E Preferred Stock and 263,261 shares of Series F Preferred
Stock. Except as otherwise provided in this Warrant Agreement and as noted above, there are no other options, warrants, conversion privileges or other rights presently outstanding to purchase or otherwise acquire any authorized but unissued shares
of Your capital stock or other of Your securities. 
 Except as set forth in Your Eighth Amended and Restated Stockholders’ Rights Agreement dated as
of October 29, 2010 (the “Stockholders’ Agreement”), a true, correct and complete copy of which has been delivered to Us prior to the issuance of this Warrant, Your stockholders do not have preemptive rights to purchase new
issuances of Your capital stock. 
  

	Þ	Other Commitments to Register Securities. Except as set forth in this Warrant Agreement and the Registration Rights Agreement, You are not, pursuant to the terms of any other agreement currently in existence,
under any obligation to register under the 1933 Act any of Your presently outstanding securities or any of Your securities which may hereafter be issued. 

  

	Þ	Exempt Transaction. Subject to the accuracy of Our representations in Section 7 hereof, the issuance of the Warrant Stock upon exercise of this Warrant Agreement will constitute a transaction exempt from
(i) the registration requirements of Section 5 of the 1933 Act, in reliance upon Section 4(2) thereof, and (ii)the qualification requirements of the applicable state securities laws. 

 

	Þ	Compliance with Rule 144. We may sell the Warrant Stock issuable hereunder in compliance with Rule 144 promulgated by the Securities and Exchange Commission, subject to the lock-up agreement in Section 7 and
the satisfaction of the requirements of Rule 144. Beginning on the expiration of the lock-up agreement in Section 7 and so long as You remain subject to the periodic reporting requirements under Section 13 or 15(d) of the 1933 Act, within
ten (10) days of Our request, You agree to furnish Us, a written statement confirming Your compliance with the filing requirements of the Securities and Exchange Commission as set forth in such Rule 144, as may be amended. 

 

	Þ	No Impairment. You agree not to, by amendment of Your Certificate of Incorporation or through a reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed under this Warrant by You, but shall at all times in good faith assist in carrying out of all the provisions of this Warrant and
in taking all such action as may be necessary or appropriate to protect Our rights under this Warrant against impairment. However, You shall not be deemed to have impaired Our rights if You amend Your Certificate of Incorporation, or the holders of
Your preferred stock waive their rights thereunder, in a manner that does not (individually or when considered in the context of any other actions being taken in connection with such amendments or waivers) affect Us in a manner different from the
effect that such amendments or waivers have on the rights of other holders of the same series and class as the Warrant Stock. 

  

					
		  	6	  	

	7.	OUR REPRESENTATIONS AND COVENANTS TO YOU. 

  

	Þ	Investment Purpose. The right to acquire Warrant Stock or the Warrant Stock issuable upon exercise of Our rights contained herein and the Common Stock issuable upon conversion will be acquired for investment
purposes and not with a view to the sale or distribution of any part thereof, and We have no present intention of selling or engaging in any public distribution of the same in violation of the 1933 Act. 

 

	Þ	Private Issue. We understand (i) that this Warrant Agreement, the Warrant Stock issuable upon exercise of this Warrant Agreement and the Common Stock issuable upon conversion of the Warrant Stock are not
registered under the 1933 Act or qualified under applicable state securities laws on the ground that the issuance contemplated by this Warrant Agreement will be exempt from the registration and qualifications requirements thereof, and (ii) that
Your reliance on such exemption is predicated on the representations set forth in this Section 7. 

  

	Þ	Disposition of Our Rights. In no event will We make a disposition of any of Our rights to acquire Warrant Stock or Warrant Stock issuable upon exercise of such rights or the Common Stock issuable upon conversion
of the Warrant Stock unless and until (i) We shall have notified You in writing of the proposed disposition, and (ii) the transferee agrees to be bound in writing to the applicable terms and conditions of this Warrant Agreement, and
(iii) if You request, We shall have furnished You with an opinion of counsel satisfactory to You and Your counsel to the effect that (A) appropriate action necessary for compliance with the 1933 Act has been taken, or (B) an exemption
from the registration requirements of the 1933 Act is available. Notwithstanding the foregoing, the restrictions imposed upon the transferability of any of Our rights to acquire Warrant Stock or Warrant Stock issuable on the exercise of such rights
or the Common Stock issuable upon conversion of the Warrant Stock do not apply to transfers from the beneficial owner of any of the aforementioned securities to its nominee or from such nominee to its beneficial owner, and shall terminate as to any
particular share of Warrant Stock when (1) such security shall have been effectively registered under the 1933 Act and sold by the holder thereof in accordance with such registration or (2) such security shall have been sold without
registration in compliance with Rule 144 under the 1933 Act, or (3) a letter shall have been issued to You at Our request by the staff of the Securities and Exchange Commission or a ruling shall have been issued to the You at Our request by
such Commission stating that no action shall be recommended by such staff or taken by such Commission, as the case may be, if such security is transferred without registration under the 1933 Act in accordance with the conditions set forth in such
letter or ruling and such letter or ruling specifies that no subsequent restrictions on transfer are required. Whenever the restrictions imposed hereunder shall terminate, as hereinabove provided, the holder of a share of Warrant Stock then
outstanding as to which such restrictions have terminated shall be entitled to receive from You, without expense to such holder, one or more new certificates for the Warrant or for such shares of Warrant Stock not bearing any restrictive legend
referring to 1933 Act registration or exemption. 

  

	Þ	Financial Risk. We have such knowledge and experience in financial and business matters and knowledge of Your business affairs and financial condition as to be capable of evaluating the merits and risks of Our
investment, and have the ability to bear the economic risks of Our investment. 

  

	Þ	Risk of No Registration. We understand that if You do not register with the Securities and Exchange Commission pursuant to Section 12 of the 1934 Act (the “1934 Act”), or file reports pursuant to
Section 15(d), of the 1934 Act, or if a registration statement covering the securities under the 1933 Act is not in effect when We desire to sell (i) the rights to purchase Warrant Stock pursuant to this Warrant Agreement, or (ii) the
Warrant Stock issuable upon exercise of the right to purchase, or (iii) the Common Stock issuable upon conversion of the Warrant Stock, We may be required to hold such securities for an indefinite period. We also understand that any sale of Our
right to purchase Warrant Stock or Warrant Stock or Common Stock issuable upon conversion of the Warrant Stock, which might be made by it in reliance upon Rule 144 under the 1933 Act may be made only in accordance with the terms and conditions of
that Rule. 

  

	Þ	Accredited Investor. We are an “accredited investor” within the meaning of the Securities and Exchange Rule 501 of Regulation D of the 1933 Act, as presently in effect. 

 

	Þ	Domicile. Our domicile for purposes of state securities laws is in the State of California. 

  

					
		  	7	  	

	Þ	Lock-Up Agreement. In consideration for You agreeing to Your obligations under this Warrant Agreement, We and each of Our transferees agrees, in connection with the first registration of Your securities under the
1933 Act, upon Your request or the request of the underwriters managing any underwritten offering of Your securities, not to (a) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or
contract to sell, grant any option, right or warrant to purchase or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock (whether such
shares or any such securities are then owned by Us or are thereafter acquired) or (b) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Common Stock,
whether any such transaction described in clause (a) or (b) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise, without Your prior written consent or the prior written consent of such
underwriters, as the case may be, for such period of time (not to exceed 180 days or such other period as may be requested by You or the underwriters to accommodate regulatory restrictions on (i) the publication or other distribution of
research reports and (ii) analyst recommendations and opinions, including, but not limited to, the restrictions contained in NASD Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions or amendments thereto) from the effective date
of such registration as You or the underwriters may specify; provided, however, that all (x) Your officers and directors and (y) Your stockholders holding three percent (3%) or more of Your total outstanding Common Stock (treating all
Your convertible, exercisable and exchangeable securities on an as-if converted to Common Stock basis) are bound by agreements that are no less restrictive. The underwriters in connection with Your initial public offering are intended third party
beneficiaries of this Lock-Up Agreement and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto. We agree that You may instruct Your transfer agent to place stop-transfer notations in its
records to enforce the provisions of this Lock-Up Agreement until the end of such period. 

  

	8.	NOTICES YOU AGREE TO PROVIDE US. 

 You agree to give Us at least twenty (20) days prior written
notice of the following events: 
  

	Þ	If You Pay a Dividend or distribution declaration upon your stock. 

  

	Þ	If You offer for subscription pro-rata to the existing shareholders additional stock or other rights (except for an offering made pursuant to Your Stockholders’ Agreement 

 

	Þ	If You consummate a Merger Event. 

  

	Þ	If You have an IPO. 

  

	Þ	If You dissolve or liquidate. 

 All notices in this Section must set forth details of the event, how the event
adjusts either Our number of shares or Our Exercise Price and the method used for such adjustment. 
 Timely Notice. Your failure to timely provide
such notice required above shall entitle Us to retain the benefit of the applicable notice period notwithstanding anything to the contrary contained in any insufficient notice received by Us. 

 

	9.	DOCUMENTS YOU WILL PROVIDE US. 

 Upon signing this Agreement You will provide Us with: 

 

	Þ	Executed originals of this Agreement, and all other documents and instruments that We may reasonably require 

  

	Þ	Secretary’s certificate of incumbency and authority 

  

	Þ	Certified copy of resolutions of Your board of directors approving this Warrant Agreement 

  

	Þ	Certified copy of Certificate of Incorporation and By-Laws as amended through the Effective Date 

  

	Þ	Current Registration Rights Agreement 

 So long as this Warrant Agreement is in effect, You shall provide
Us with the following: 
  

	 	Þ	You shall submit to Us information that We may reasonably request from time to time in order to satisfy the reasonable requests of our independent accounting firm in connection with the audit of the fair market value of
this Warrant Agreement recorded in Our books and records, including but not limited to a written certification by the Company or its advisors of the current fair market value of the Warrant Stock or Your capital stock and shall include information
supporting the reasonableness of the fair market value indicated by such certification. 

  

					
		  	8	  	

	Þ	You shall submit to Us any documents and information that We may reasonably request from time to time and are necessary to implement the provisions and purposes of this Warrant Agreement. 

 

	10.	REGISTRATION RIGHTS UNDER THE 1933 ACT. 

 The shares of Your common stock into which the Warrant Stock is
convertible shall have “piggyback” and “Form S-3” registration rights as set forth in the Registration Rights Agreement, dated as of October 29, 2010 (as amended, the “Registration Rights Agreement”). 

 

	11.	OTHER LEGAL PROVISIONS THE PARTIES WILL ABIDE BY. 

 Effective Date. This Warrant Agreement shall
be construed and shall be given effect in all respects as if it had been executed and delivered by the Parties on the date hereof. This Warrant Agreement shall be binding upon any of the successors or assigns of the Parties. 

Attorney’s Fees. In any litigation, arbitration or court proceeding between the Parties relating to this Warrant Agreement, the prevailing party
shall be entitled to attorneys’ fees and expenses and all costs of proceedings incurred in enforcing this Warrant Agreement. 
 Governing Law.
This Warrant Agreement shall be governed by and construed for all purposes under and in accordance with the laws of the State of California without giving effect to that body of law pertaining to conflicts of laws. 

Consent to Jurisdiction and Venue. All judicial proceedings arising in or under or related to this Warrant Agreement may be brought in any state or
federal court of competent jurisdiction located in the State of California. By execution and delivery of this Warrant Agreement, each party hereto generally and unconditionally: (a) consents to personal jurisdiction in San Mateo County, State
of California; (b) waives any objection as to jurisdiction or venue in San Mateo County, State of California; (c) agrees not to assert any defense based on lack of jurisdiction or venue in the aforesaid courts; and (d) irrevocably
agrees to be bound by any judgment rendered thereby in connection with this Warrant Agreement. Service of process on any party hereto in any action arising out of or relating to this agreement shall be effective if given in accordance with the
requirements for notice set forth in this Section, and shall be deemed effective and received as set forth therein. Nothing herein shall affect the right to serve process in any other manner permitted by law or shall limit the right of either party
to bring proceedings in the courts of any other jurisdiction. 
 Mutual Waiver of Jury Trial; Judicial Reference. Because disputes arising in
connection with complex financial transactions are most quickly and economically resolved by an experienced and expert person and the Parties wish applicable state and federal laws to apply (rather than arbitration rules), The Parties desire that
their disputes be resolved by a judge applying such applicable laws. EACH OF THE PARTIES SPECIFICALLY WAIVES ANY RIGHT THEY MAY HAVE TO TRIAL BY JURY OF ANY CAUSE OF ACTION, CLAIM, CROSS-CLAIM, COUNTERCLAIM, THIRD PARTY CLAIM OR ANY OTHER CLAIM
(COLLECTIVELY, “CLAIMS”) ASSERTED BY YOU AGAINST US OR OUR ASSIGNEE OR BY US OR OUR ASSIGNEE AGAINST YOU. IN THE EVENT THAT THE FOREGOING JURY TRIAL WAIVER IS NOT ENFORCEABLE, ALL CLAIMS, INCLUDING ANY AND ALL QUESTIONS OF LAW OR
FACT RELATING THERETO, SHALL, AT THE WRITTEN REQUEST OF ANY PARTY, BE DETERMINED BY JUDICIAL REFERENCE PURSUANT TO THE CALIFORNIA CODE OF CIVIL PROCEDURE (“REFERENCE”). THE PARTIES SHALL SELECT A SINGLE NEUTRAL REFEREE, WHO SHALL BE A
RETIRED STATE OR FEDERAL JUDGE. IN THE EVENT THAT THE PARTIES CANNOT AGREE UPON A REFEREE, THE REFEREE SHALL BE APPOINTED BY THE COURT. THE REFEREE SHALL REPORT A STATEMENT OF DECISION TO THE COURT. NOTHING IN THIS SECTION SHALL LIMIT THE RIGHT OF
ANY PARTY AT ANY TIME TO EXERCISE LAWFUL SELF-HELP REMEDIES, FORECLOSE AGAINST COLLATERAL OR OBTAIN PROVISIONAL REMEDIES. THE PARTIES SHALL BEAR THE FEES AND EXPENSES OF THE REFEREE EQUALLY UNLESS THE REFEREE ORDERS OTHERWISE. THE REFEREE SHALL ALSO
DETERMINE ALL ISSUES RELATING TO THE APPLICABILITY, INTERPRETATION, AND ENFORCEABILITY OF THIS SECTION. THE PARTIES ACKNOWLEDGE THAT THE CLAIMS WILL NOT BE ADJUDICATED BY A JURY. This waiver extends to all such Claims, including Claims that involve
Persons other than You and Us; Claims that arise out of or are in any way connected to the relationship between You and Us; and any Claims for damages, breach of contract, specific performance, or any equitable or legal relief of any kind, arising
out of this Warrant Agreement. 

  

					
		  	9	  	

 Counterparts. This Warrant Agreement may be executed in two or more counterparts, each of which shall be
deemed an original, but all of which together shall constitute one and the same instrument. 
 Notices. Any notice required or permitted under this
Warrant Agreement shall be given in writing and shall be deemed effectively given upon the earlier of (1) actual receipt or 3 days after mailing if mailed postage prepaid by regular or airmail to Us or You or (2) one day after it is sent
by overnight mail via nationally recognized courier or (3) on the same day as sent via confirmed facsimile transmission, provided that the original is sent by personal delivery or mail by the sending party. 

Remedies. In the event of any default hereunder, the non-defaulting party may proceed to protect and enforce its rights either by suit in equity and/or
by action at law, including but not limited to an action for damages as a result of any such default, and/or an action for specific performance for any default where such party will not have an adequate remedy at law and where damages will not be
readily ascertainable. Each party expressly acknowledges and agrees that there is no adequate remedy at law for any breach of this Warrant Agreement and that in the event of any breach of this Agreement, the injured party shall be entitled to
specific performance of any or all provisions hereof or an injunction prohibiting the other party from continuing to commit any such breach of this Agreement. 

Survival. The representations, warranties, covenants, and conditions of the Parties contained herein or made pursuant to this Warrant Agreement shall
survive the execution and delivery of this Warrant Agreement. 
 Severability. In the event any one or more of the provisions of this Warrant
Agreement shall for any reason be held invalid, illegal or unenforceable, the remaining provisions of this Warrant Agreement shall be unimpaired, and the invalid, illegal or unenforceable provision shall be replaced by a mutually acceptable valid,
legal and enforceable provision, which comes closest to the intention of the Parties underlying the invalid, illegal or unenforceable provision. 

Entire Agreement. This Warrant Agreement constitutes the entire agreement between the Parties pertaining to the subject matter contained in it and
supersedes all prior and contemporaneous agreements, representations and undertakings of the Parties, whether oral or written, with respect to such subject matter. 

Amendments. Any provision of this Warrant Agreement may only be amended by a written instrument signed by the Parties. 

Lost Warrants or Stock Certificates. You covenant to Us that, upon receipt of evidence reasonably satisfactory to Us of the loss, theft, destruction or
mutilation of this Warrant Agreement or any stock certificate and, in the case of any such loss, theft or destruction, upon receipt of an indemnity reasonably satisfactory to You, or in the case of any such mutilation upon surrender and cancellation
of such Warrant Agreement or stock certificate, You will make and deliver a new Warrant Agreement or stock certificate, of like tenor, in lieu of the lost, stolen, destroyed or mutilated Warrant Agreement or stock certificate. 

Rights as Stockholders. We shall not, as a party to this Warrant Agreement, be entitled to vote or receive dividends or be deemed the holder of the
Warrant Stock or any of Your other securities which may at any time be issuable upon the exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon Us any of the rights of one of Your stockholders or any right
to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to receive dividends or subscription rights or otherwise until this Warrant Agreement is exercised and the shares purchasable upon the
exercise hereof shall have become deliverable, as provided herein. 
 Facsimile Signatures. This Warrant Agreement may be executed and delivered by
facsimile and upon such delivery the facsimile signature will be deemed to have the same effect as if the original signature had been delivered to the other party. 

  

					
		  	10	  	

 IN WITNESS WHEREOF, each of the Parties have caused this Warrant Agreement to be executed by its officers
who are duly authorized as of the Effective Date. 
  

			
	You: BLOOM ENERGY CORPORATION
		
	Signature:	 	 
		
	Print Name:	 	 
		
	Title:	 	 

  

			
	Us: TRIPLEPOINT CAPITAL LLC
		
	Signature:	 	 
		
	Print Name:	 	 
		
	Title:	 	 

 [SIGNATURE PAGE TO AMENDED AND RESTATED PLAIN ENGLISH 

WARRANT AGREEMENT 0674-W-01] 

  

					
		  	11	  	

 EXHIBIT I 

NOTICE OF EXERCISE 
 To:
[                                        ]

  

	1.	We hereby elect to purchase [            ] shares of the Series [            ]
Preferred Stock of [            ], pursuant to the terms of the Plain English Warrant Agreement dated the
[            ] day of [            ], [200    ] (the “Plain English Warrant
Agreement”) between You and Us, We hereby tender here payment of the purchase price for such shares in full, together with all applicable transfer taxes, if any. 

 

	2.	Method of Exercise (Please initial the applicable blank) 

  

	 	a.	             The undersigned elects to exercise the Plain English Warrant Agreement by means of a cash payment, and gives You full payment for the
purchase price of the shares being purchased, together with all applicable transfer taxes, if any. 

  

	 	b.	             The undersigned elects to exercise the Plain English Warrant Agreement by means of the Net Issuance Exercise method of Section 3 of
the Plain English Warrant Agreement. 

  

	3.	In exercising Our rights to purchase the Series [            ] Preferred Stock of
[                    ], We hereby confirm and acknowledge the investment representations, warranties and covenants made in Section 7 of
the Plain English Warrant Agreement. 

 Please issue a certificate or certificates representing these purchased shares of Series
[            ] Preferred Stock in Our name or in such other name as is specified below. 

	
	   

	(Name)
	
	   

	(Address)

  

			
	US: TRIPLEPOINT CAPITAL LLC
		
	By:	 	 
		
	Title:	 	 
		
	Date:	 	 

  

					
		  	12	  	

 EXHIBIT II 

ACKNOWLEDGMENT OF EXERCISE 

[                         
                           ], hereby acknowledges receipt of the “Notice of Exercise” from
TRIPLEPOINT CAPITAL LLC, to purchase [            ] shares of the Series [            ] Preferred Stock of
[                    ], pursuant to the terms of the Plain English Warrant Agreement, and further acknowledges that
[            ] shares remain subject to purchase under the terms of the Plain English Warrant Agreement. 
  

							
	        YOU:	 		 	 
				
		 		 	By:	 	 
				
		 		 	Title:	 	 
				
		 		 	Date:	 	 

  

					
		  	13	  	

 EXHIBIT III 

TRANSFER NOTICE 
 FOR VALUE RECEIVED,
the foregoing Plain English Warrant Agreement and all rights evidenced thereby are hereby transferred and assigned to 
  

 

					
	(Please Print)	  	 	  	

  

					
	Whose address is	  	 	  	
			
	 	  	 	  	

					
			
	Dated:	  	 	  	
			
	Holder’s Signature:	  	 	  	
			
	Holder’s Address:	  	 	  	
			
	Transferee’s Signature:	  	 	  	
			
	Transferee’s Address:	  	 	  	
			
	Signature Guaranteed:	  	 	  	

 NOTE: The signature to this Transfer Notice must correspond with the name as it appears on the face of the Plain
English Warrant Agreement, without alteration or enlargement or any change whatever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Plain
English Warrant Agreement. 

  

					
		  	14EX-4.11

 Exhibit 4.11 

THIS WARRANT AND THE SECURITIES THAT MAY BE PURCHASED PURSUANT TO THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED. SUCH SECURITIES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

 BLOOM ENERGY CORPORATION 

AGREEMENT AND WARRANT TO PURCHASE SERIES F PREFERRED STOCK 

Effective Date: July 1, 2014 

Void After: July 1, 2021 

This Agreement and Warrant to Purchase Series F Preferred Stock (this “Agreement” or “Warrant”) certifies that, for value
received, PE12GVVC (US DIRECT) LTD., or any permitted transferee (the “Holder”), is entitled, subject to the terms set forth below, to purchase from Bloom Energy Corporation, a Delaware corporation (the “Company”), up to 330,749
shares of Series F Preferred Stock of the Company (“Series F Preferred Stock”), upon surrender of this Warrant, at the principal office of the Company referred to below, with the subscription form attached hereto duly executed, and
simultaneous payment therefor, as hereinafter provided, of the aggregate Exercise Price (as defined below). The Exercise Price and the number of shares of Series F Preferred Stock purchasable hereunder are subject to adjustment as provided herein.

 1. Number of Shares. Subject to any adjustments pursuant to Section 11 herein, this Warrant may be exercised, in whole
or in part, for up to 330,749 shares of Series F Preferred Stock (the “Warrant Shares”). 
 2. Exercise Price.
Subject to any adjustments pursuant to Section 11 herein, the per share purchase price of the Series F Preferred Stock (the “Exercise Price”) for which this Warrant may be exercised shall be $18.52. 

3. Exercise of Warrant. 

3.1 Time of Exercise. Subject to the terms and conditions set forth herein, this Warrant shall be exercisable, in whole or in part, at
any time or from time to time prior to 5:00 p.m. (Pacific Standard Time) on July 1, 2021 (the “Expiration Date”). 

Notwithstanding the foregoing, unless the Holder provides the Company with prior written notice to the contrary, this Warrant shall terminate
immediately prior to the closing of (i) a merger, consolidation, amalgamation or similar transaction of the Company with or into any other corporation or corporations in which the stockholders of the Company immediately prior to such
transaction shall own, immediately thereafter, less than fifty percent (50%) of the voting securities of the surviving corporation or its parent or (ii) a sale of all or substantially all of the assets of the Company (each a “Change
of Control Event”). The Company shall give the Holder written notice of a Change of Control Event not later than thirty (30) days prior to the closing of such Change of Control Event. 

  

					
		  	-1-	  	

 3.2 Method of Exercise. The exercise shall be effected by (a) the surrender of this
Warrant at the principal office of the Company as set forth in Section 12.6 (or such other office or agency of the Company as may be designated by notice in writing to the Holder at the address of the Holder appearing on the books of the
Company), (b) delivery of the Notice of Exercise attached hereto as Exhibit A (unless the Holder is exercising by means of a “net exercise” as provided for in Section 4 below, in which case the Holder shall deliver the Net
Exercise Notice attached hereto as Exhibit B (the “Net Exercise Notice”)), and (c) unless payment of the Exercise Price is made pursuant to a “net exercise” as provided under Section 4 below, payment of the
Exercise Price in cash, check or wire transfer of immediately available funds. 
 3.3 Effect of Exercise. This Warrant (or the
portion thereof exercised) shall be deemed to have been exercised immediately prior to the close of business on the date of its surrender for exercise as provided above, and the Holder shall be treated for all purposes as the holder of record of
such Warrant Shares as of the close of business on such date. The Company, at its expense, shall, within three (3) business days after exercise, issue and deliver to the Holder (i) a certificate or certificates for the number of Warrant Shares
issuable upon such exercise and, (ii) unless this Warrant shall have expired or been exercised in full, a new warrant representing the right to acquire the number of Warrant Shares represented by the surrendered Warrant, if any, that shall not have
been exercised. 
 4. Net Exercise. 

4.1 Net Issue Exercise. In lieu of exercising this Warrant via payment by cash, check or wire transfer, the Holder may elect to receive
shares equal to the value of this Warrant (or the portion thereof being exercised) by surrender of this Warrant at the principal office of the Company together with the completed Net Exercise Notice indicating the Holder’s election to exercise
this Warrant by means of a “net exercise,” in which event the Company shall issue to the Holder a number of shares of Common Stock computed using the following formula: 

X = Y (A - B)  
 A 

 

							
	Where	  	X	  	=	  	the number of Warrant Shares to be issued to the Holder.
		  		  		  	
		  	Y	  	=	  	the number of Warrant Shares purchasable under this Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant being exercised (at the date of such calculation).
		  		  		  	
		  	A	  	=	  	the fair market value (as determined below) of one Warrant Share (at the date of such calculation).
		  		  		  	
		  	B	  	=	  	the Exercise Price (as adjusted to the date of such calculation).

 If the above calculation results in a negative number, then no shares of Common Stock shall be issued or
issuable upon exercise of this Warrant. 

  

					
		  	-2-	  	

 4.2 Fair Market Value. For purposes of this Section 4, the “fair market
value” of one Warrant Share shall be determined by the Company’s Board of Directors in good faith which determination shall take in account any factors that the Company’s Board of Directors (the “Board”) deems relevant,
including, without limitation, any independent third party valuation but, for the avoidance of doubt, without giving effect to lack of control or lack of marketability; provided however, that if the time of exercise coincides with the Company’s
underwritten initial public offering, the “fair market value” shall be the price at which the Company’s Common Stock are sold at such public offering, and further provided, that where there exists a public market for the Warrant
Shares at the time of such exercise, the “fair market value” per Warrant Share shall be the average of the closing prices of the Warrant Shares on any such exchange on which the Warrant Shares is listed, whichever is applicable, for the
twenty-one (21) trading days prior to the date of the delivery of the Net Exercise Notice. 
 5. No Fractional Shares or
Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. In lieu of any fractional share to which the Holder would otherwise be entitled, the Company shall, within three
(3) business days after exercise, make a payment to the Holder, via cash, check or wire transfer of immediately available funds, equal to the Exercise Price multiplied by such fraction computed to the nearest whole cent less the prorated
Exercise Price for such fractional share. 
 6. No Rights as Stockholder. Until the Warrant shall have been exercised as
provided herein, solely by virtue of this Warrant, the Holder shall not be entitled to vote or receive dividends or be deemed the holder of Series F Preferred Stock or any other securities of the Company that may at any time be issuable on the
exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon the Holder, as such, any of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted
to stockholders at any meeting thereof, or to give or withhold consent to any corporate action, or to receive dividends or subscription rights or otherwise. Nothing contained in this Warrant shall be construed as imposing any liabilities on the
Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or creditors of the Company. 

7. Transfer of Warrant; Registration Rights. 

7.1 Transferability of Warrant. Subject to Section 7.2, this Warrant and all rights hereunder are transferable, in whole or in
part, upon the books of the Company by the Holder in person or by duly authorized attorney, and a new warrant shall be made and delivered by the Company, of the same tenor and date as this Warrant but registered in the name of one or more
transferees, upon surrender of this Warrant, duly endorsed, to the office or agency of the Company described in Section 3.2. All expenses (other than stock transfer taxes) and other charges payable in connection with the preparation, execution
and delivery of the new warrants pursuant to this Section 7.1 shall be paid by the Company. 
 7.2 Company Consent to Transfers.
Notwithstanding anything to the contrary set forth in Section 7.1, Holder may not transfer this Warrant, or any rights hereunder, prior to an initial public offering of the Company’s common stock without the prior written consent of the
Company, such consent not to be unreasonably withheld or delayed. 

  

					
		  	-3-	  	

 Notwithstanding the foregoing, the written consent of the Company will not be required and the
Holder shall only be required to provide the Company with prior written notice of any sale, transfer or other disposition of this Warrant prior to an initial public offering of the Company’s Common Stock if the sale, transfer or other
disposition is to (i) an “Affiliate” (as such term is defined in Rule 144(a) promulgated under the Securities Act, which for purposes of this Agreement shall be deemed to include any direct or indirect partner or other equityholder of
the Holder and shall include any investment entity under common management with the Holder) of the Holder, (ii) to the direct or indirect partners or retired partners of the Holder, if the Holder is a partnership, (iii) to the direct or
indirect shareholders of the Holder, if the Holder is a corporation, or (iv) to the direct or indirect members of the Holder, if the Holder is a limited liability company. 

7.3 Register. The Company will maintain a register (the “Warrant Register”) containing the name and address of the Holder.
The Holder of this Warrant may change its address as shown on the Warrant Register by written notice to the Company requesting such change. Any notice or written communication required or permitted to be given to the Holder may be delivered or given
by mail to the Holder as shown on the Warrant Register and at the address shown on the Warrant Register. 
 8. Representations and Warranties of the
Holder and Restrictions on Transfer Imposed by the Securities Act. 
 8.1 Representations and Warranties by the Holder. The
Holder hereby represents and warrants to the Company as follows: 
 (a) The Holder has full legal capacity, power and authority to execute
and deliver this Agreement and to perform its obligations hereunder. This Agreement is a valid and binding obligation of the Holder, enforceable in accordance with its terms, except as limited by bankruptcy, insolvency or other laws of general
application relating to or affecting the enforcement of creditors’ rights generally and general principles of equity. 
 (b) The
Warrant and the Warrant Shares are being acquired for the Holder’s own account, for investment and not with a view to, or for resale in connection with, any distribution or public offering thereof within the meaning of the Securities Act or any
state Blue Sky laws. 
 (c) The Holder understands that the Warrant and the Warrant Shares have not been registered under the Securities
Act by reason of their issuance in a transaction exempt from the registration and prospectus delivery requirements of the Securities Act pursuant to Section 4(2) thereof, that the Company has no present intention of registering the Warrant or
the Warrant Shares, that the Warrant and the Warrant Shares must be held by the Holder indefinitely, and that the Holder must therefor bear the economic risk of such investment indefinitely, unless a subsequent disposition thereof is registered
under the Securities Act or is exempt from registration. 

  

					
		  	-4-	  	

 (d) The Holder agrees that it will not offer, sell or otherwise dispose of this Warrant or any
Warrant Shares to be issued upon exercise hereof except under circumstances which will not result in a violation of the Securities Act or any state securities law. This Warrant and all Warrant Shares issued upon exercise of this Warrant shall be
stamped or imprinted with legends in substantially the following form: 
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN
ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR REGISTERED OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. THESE SECURITIES MAY NOT BE OFFERED, SOLD, PLEDGED OR
TRANSFERRED UNLESS (I) THERE IS AN EFFECTIVE REGISTRATION STATEMENT COVERING SUCH OFFER, SALE OR TRANSFER OR (II) THERE IS AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE COMPANY, THAT EXEMPTIONS FROM THE REGISTRATION, QUALIFICATION AND
PROSPECTUS DELIVERY REQUIREMENTS OF THE SECURITIES ACT AND OF ANY APPLICABLE STATE SECURITIES LAWS FOR SUCH OFFER, SALE OR TRANSFER ARE AVAILABLE. 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP PERIOD FOLLOWING THE EFFECTIVE DATE OF THE COMPANY’S INITIAL
UNDERWRITTEN PUBLIC OFFERING AND MAY NOT BE SOLD OR OTHERWISE DISPOSED OF BY THE HOLDER WITHOUT THE CONSENT OF THE COMPANY OR THE MANAGING UNDERWRITER. 

(e) During the negotiation of the transactions contemplated herein, the Holder and its representatives and legal counsel have been afforded
full and free access to corporate books, financial statements, records, contracts, documents, and other information concerning the Company and to its offices and facilities, have been afforded an opportunity to ask such questions of the
Company’s officers, employees, agents, accountants and representatives concerning the Company’s business, operations, financial condition, assets, liabilities and other relevant matters as they have deemed necessary or desirable, and have
been given all such information as has been requested, in order to evaluate the merits and risks of the prospective investments contemplated herein. 

(f) The Holder and its representatives have been solely responsible for the Holder’s own “due diligence” investigation of the
Company and the Company’s management and business, for its own analysis of the merits and risks of this investment, and for its own analysis of the fairness and desirability of the terms of the investment. In taking any action or performing any
role relative to the arranging of the proposed investment, the Holder has acted solely in its own interest, and the Holder (or any of its agents or employees) has not acted as an agent of the Company. The Holder has such knowledge and experience in
financial and business matters that the Holder is capable of evaluating the merits and risks of the purchase of the Warrant pursuant to the terms of this Agreement and of protecting the Holder’s interests in connection therewith. 

  

					
		  	-5-	  	

 (g) The Holder is an “accredited investor” as defined in Rule 501 of the Securities
Act. 
 (h) The Holder understands that it has had the opportunity to review with its own tax advisors the federal, state, local and
foreign tax consequences of this investment and the transactions contemplated by this Agreement. It understands that it (and not the Company) shall be responsible for its own tax liability that may arise as a result of this investment or the
transactions contemplated by this Agreement. 
 9. [Reserved]. 

10. Lost Documents. Upon receipt by the Company of evidence of the loss, theft, destruction or mutilation of, and upon surrender
and cancellation of this Warrant, if mutilated, the Company will make and deliver to the Holder, in lieu of this Warrant, a new Warrant of the same series and of like tenor of this Warrant. 

11. Adjustments. The number of shares purchasable hereunder are subject to adjustment from time to time as follows: 

11.1 Reorganization, Reclassification, Merger or Conveyance. If any capital reorganization or reclassification of the capital stock of
the Company shall be effected in such a way that holders of Series F Preferred Stock shall be entitled to receive stock, securities or assets with respect to or in exchange for Series F Preferred Stock (including, for the avoidance of doubt, in the
event of an initial public offering of the Company’s common stock), or in the event the Company (or any such other corporation) merges with or into another corporation or conveys all or substantially all of its assets to another corporation and
this Warrant does not terminate in accordance with the, provisions of Section 3.1 above, then, as a condition of such reorganization, reclassification, merger or conveyance, lawful and adequate provisions shall be made whereby this Warrant
shall remain outstanding upon the terms and conditions specified herein and shall thereafter be automatically (and without further action) exercisable for (in lieu of the Warrant Shares immediately theretofore receivable upon the exercise of the
Warrant) such shares of stock, securities or assets (including cash) as may be issued or payable with respect to or in exchange for the number of Warrant Shares immediately theretofore so receivable, in connection with such reorganization,
reclassification, merger or conveyance. In any such case, the Company should ensure that the rights and interests of the Holder hereunder will not be disproportionately adversely affected relative to the other holders of the Company’s Series F
Preferred Stock. 
 11.2 Split, Subdivision or Combination of Shares. If the Company at any time while this Warrant, or any portion
thereof, remains outstanding and unexpired shall split, subdivide or combine the securities as to which purchase rights under this Warrant exist, into a different number of securities of the same class, the Exercise Price for such securities shall
be proportionately decreased in the case of a split or subdivision or proportionately increased in the case of a combination and the number of the securities as to which purchaser rights under this Warrant exist shall be increased or decreased
proportionately in accordance with such split subdivision or combination, in each case such that, following any such split subdivision or combination, Holder shall be entitled to purchase the number of Common Stock which Holder would have owned or
otherwise been entitled to receive in respect of shares of Common Stock subject to this Warrant after such date, had this Warrant been exercised immediately prior to such date. 

  

					
		  	-6-	  	

 11.3 Certificate as to Adjustments. Upon the occurrence of each adjustment or readjustment
pursuant to this Section 11, the Company at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to the Secretary of the Company for filing in the Company’s records and to the
Holder a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Company shall, upon the written request, at any time, of the Holder, furnish or cause to be
furnished to the Holder a like certificate setting forth: (a) such adjustments and readjustments; (b) the Exercise Price at the time in effect; and (c) the number of shares and the amount, if any, of other property that at the time
would be received upon the exercise of the Warrant. No such adjustment or change shall compel immediate exercise of this Warrant or otherwise affect the Expiration Date of this Warrant. 

11.4 Other Adjustments (No Impairment). If any change in the Warrant Shares or any other event occurs as to which the other provisions
of this Section 11 are not strictly applicable or if strictly applicable would not fairly protect the purchase rights of the Holder in accordance with such provisions, then the Company shall make an adjustment in the number and class of shares
available under the Warrant, the Exercise Price or the application of such provisions, so as to protect such purchase rights as aforesaid. 

12. General Provisions. 

12.1 Governing Law. This Warrant shall be governed by and construed under the laws of the State of Delaware, excluding that body of law
relating to conflict of laws. 
 12.2 Consent to Jurisdiction. Each of the parties hereto irrevocably submits to the exclusive
jurisdiction of the Court of Chancery of the State of Delaware or, if such Court of Chancery shall lack subject matter jurisdiction, the Federal courts of the United States of America located in the County of New Castle, Delaware, for the purposes
of any suit, action or other proceeding arising out of this Agreement or any of the Transactions. Each of the parties hereto further agrees that service of any process, summons, notice or document by U.S. registered mail to such party’s
respective address set forth in Section 12.6 shall be effective service of process for any action, suit or proceeding in Delaware with respect to any matters to which it has submitted to jurisdiction as set forth above in the immediately
preceding sentence. Each of the parties hereto irrevocably and unconditionally waives any objection to the laying of venue of any action, suit or proceeding arising out of this Agreement or the Transactions in the Court of Chancery of the State of
Delaware or the Federal courts of the United States of America located in the County of New Castle, Delaware, and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such action, suit or
proceeding brought in any such court has been brought in an inconvenient forum. 
 12.3 Waiver of Jury Trial. THE PARTIES HEREBY
WAIVE ANY RIGHT TO TRIAL BY JURY IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY, WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER SOUNDING IN

  

					
		  	-7-	  	

 
CONTRACT, TORT OR OTHERWISE. THE PARTIES AGREE THAT ANY OF THEM MAY FILE A COPY OF THIS SECTION 12.3 WITH ANY COURT AS WRITTEN EVIDENCE OF THE KNOWING, VOLUNTARY AND BARGAINED-FOR AGREEMENT AMONG
THE PARTIES IRREVOCABLY TO WAIVE TRIAL BY JURY AND THAT ANY ACTION OR PROCEEDING WHATSOEVER AMONG THEM RELATING TO THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY SHALL INSTEAD BE TRIED IN A COURT OF COMPETENT JURISDICTION BY A JUDGE SITTING
WITHOUT A JURY. 
 12.4 Survival. The representations, warranties, covenants and agreements made herein shall survive the execution
of this Agreement and the exercise of this Warrant. 
 12.5 Successors and Assigns. Except as otherwise expressly provided herein,
the provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto. 

12.6 Notices, etc. All notices and other communications required or permitted hereunder shall be in writing and shall be sent via
facsimile, overnight courier service or mailed by certified or registered mail, postage prepaid, return receipt requested, addressed or sent (a) if to the Holder, at the address or facsimile number of the Holder set forth below such
party’s name on the signature page hereto, or at such other address or number as the Holder shall have furnished to the Company in writing, or (b) if to the Company, at 1299 Orleans Dr., Sunnyvale, CA 94089, facsimile: (408) 543-1501,
attention: Chief Executive Officer or at such other address or number as the Company shall have furnished to the Holder in writing. 
 All
such notices and communications shall be effective (a) when sent by Federal Express or other overnight service of recognized standing, on the business day following the deposit with such service; (b) when mailed, by registered or certified
mail, first class postage prepaid and addressed as aforesaid through the United States Postal Service or Canada Post, four days after being deposited in the mail; (c) when delivered by hand, upon delivery; and (d) when faxed, upon
confirmation of receipt. 
 12.7 Amendments. This Warrant may be amended and the observance of any term of this Warrant may be waived
only with the written consent of the Company and the Holder. 
 12.8 Severability. In case any provision of this Agreement shall be
declared invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. Upon such determination that any term or other provision is invalid, illegal or
incapable of being enforced, the parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the Transactions are consummated
as originally contemplated to the fullest extent possible. 
 12.9 Counterparts. This Agreement may be executed in any number of
counterparts each of which shall be an original, but all of which together shall constitute one instrument. 

  

					
		  	-8-	  	

 IN WITNESS WHEREOF, the Company and the Holder have caused the Warrant to be
executed as of the effective date of this Warrant set forth above. 
  

					
	BLOOM ENERGY CORPORATION
		
	By:	 	/s/ William H. Kurtz
		 	Name:	 	William H. Kurtz
		 	Title:	 	Chief Financial and Commercial Officer

  

			
	 AGREED AND ACCEPTED:
  

PE12GVVC (US DIRECT) LTD.

		
	By:	 	/s/ David Goerz
	Name:	 	David Goerz
	Title:	 	Director
	Address:	 	# 1100 – 10830 Jasper Avenue Edmonton, AB T5J 2B3

  

					
		  		  	

 EXHIBIT A 

NOTICE OF EXERCISE 
 To: BLOOM ENERGY
CORPORATION 
 (1) The undersigned hereby elects to purchase
                     shares of Series F Preferred Stock (“Series F Preferred Stock”) of Bloom Energy Corporation pursuant to the
terms of the attached Agreement and Warrant to Purchase Series F Preferred Stock (the “Warrant”) for an aggregate Exercise Price of
                    , and tenders herewith payment of the Exercise Price for such shares in full in the following manner:
                            . 

(2) The undersigned hereby confirms and acknowledges that the representations and warranties set forth in Section 8 of the Warrant remain
true and correct concerning the Holder as of the date hereof, that the shares of Series F Preferred Stock are being acquired solely for the account of the undersigned and not as a nominee for any other party, and for investment, and that the
undersigned will not offer, sell, or otherwise dispose of any such shares of Series F Preferred Stock except under circumstances that will not result in a violation of the Securities Act of 1933, as amended, or any state securities laws. 

(3) Please issue a certificate or certificates representing said shares of Series F Preferred Stock in the name of the undersigned or in such
other name as is specified below. A new warrant evidencing the remaining shares of Warrant Shares covered by the Warrant, but not yet subscribed for and purchased, if any, should be issued in the name set forth below. 

 

			
	PE12GVVC (US DIRECT) LTD.
		
		 	 
		 	 Print Name
  

		 	 Signature
  

		 	 Title
  

		 	 Date
  

  

					
		  		  	

 EXHIBIT B 

NET EXERCISE NOTICE 
 To: BLOOM ENERGY
CORPORATION 
 (1) The undersigned hereby elects to convert the attached Warrant into
                     shares of Series F Preferred Stock (“Series F Preferred Stock”) of Bloom Energy Corporation pursuant to the
terms of the attached Agreement and Warrant to Purchase Series F Preferred Stock (the “Warrant”) for an aggregate Exercise Price of
                    , in the form of a cashless exercise in accordance with Section 4 of the Warrant. 

(2) In converting such Warrant, the undersigned hereby confirms and acknowledges that the representations and warranties set forth in
Section 8 of the Warrant remain true and correct concerning the Holder as of the date hereof, that the shares of Series F Preferred Stock are being acquired solely for the account of the undersigned and not as a nominee for any other party, and
for investment, and that the undersigned will not offer, sell, or otherwise dispose of any such shares of Series F Preferred Stock except under circumstances that will not result in a violation of the Securities Act of 1933, as amended, or any state
securities laws. 
 (3) Please issue a certificate or certificates representing said shares of Series F Preferred Stock in the name of the
undersigned or in such other name as is specified below. A new warrant evidencing the remaining shares of Warrant Shares covered by the Warrant, but not yet subscribed for and purchased, if any, should be issued in the name set forth below. 

 

			
	PE12GVVC (US DIRECT) LTD.
		
		 	 
		 	 Print Name
  

		 	 Signature
  

		 	 Title
  

		 	Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}]]